Wells Trecaso Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.43M | Sell |
6,172
-1,767
| -22% | -$360K | 0.68% | 39 |
|
|
2025
Q2 | $1.47M | Sell |
7,939
-248
| -3% | -$46.1K | 0.45% | 44 |
|
|
2025
Q1 | $1.72M | Sell |
8,187
-396
| -5% | -$77K | 0.57% | 40 |
|
|
2024
Q4 | $1.53M | Sell |
8,583
-231
| -3% | -$42.5K | 0.5% | 42 |
|
|
2024
Q3 | $1.74M | Sell |
8,814
-532
| -6% | -$99.3K | 0.57% | 37 |
|
|
2024
Q2 | $1.6M | Sell |
9,346
-123
| -1% | -$20.4K | 0.55% | 38 |
|
|
2024
Q1 | $1.72M | Sell |
9,469
-1,074
| -10% | -$185K | 0.61% | 34 |
|
|
2023
Q4 | $1.63M | Sell |
10,543
-500
| -5% | -$72.9K | 0.66% | 30 |
|
|
2023
Q3 | $1.65M | Sell |
11,043
-399
| -3% | -$58.6K | 0.73% | 31 |
|
|
2023
Q2 | $1.54M | Sell |
11,442
-238
| -2% | -$34.9K | 0.66% | 31 |
|
|
2023
Q1 | $1.86M | Sell |
11,680
-648
| -5% | -$99.1K | 0.86% | 30 |
|
|
2022
Q4 | $1.99M | Buy |
12,328
+2
| +0% | +$307 | 0.99% | 29 |
|
|
2022
Q3 | $1.65M | Sell |
12,326
-743
| -6% | -$107K | 0.91% | 30 |
|
|
2022
Q2 | $2M | Sell |
13,069
-283
| -2% | -$43.2K | 1.04% | 29 |
|
|
2022
Q1 | $2.16M | Buy |
13,352
+124
| +0.9% | +$18K | 0.96% | 29 |
|
|
2021
Q4 | $1.79M | Sell |
13,228
-198
| -1% | -$23.4K | 0.78% | 30 |
|
|
2021
Q3 | $1.45M | Sell |
13,426
-322
| -2% | -$36.8K | 0.69% | 33 |
|
|
2021
Q2 | $1.55M | Sell |
13,748
-123
| -0.9% | -$13.9K | 0.74% | 32 |
|
|
2021
Q1 | $1.5M | Sell |
13,871
-1,568
| -10% | -$168K | 0.79% | 30 |
|
|
2020
Q4 | $1.65M | Sell |
15,439
-748
| -5% | -$71.9K | 0.92% | 29 |
|
|
2020
Q3 | $1.42M | Sell |
16,187
-304
| -2% | -$28.6K | 0.9% | 28 |
|
|
2020
Q2 | $1.62M | Buy |
16,491
+862
| +6% | +$75.9K | 1.12% | 24 |
|
|
2020
Q1 | $1.19M | Sell |
15,629
-189
| -1% | -$16.1K | 1.06% | 27 |
|
|
2019
Q4 | $1.4M | Sell |
15,818
-748
| -5% | -$62.1K | 1.01% | 27 |
|
|
2019
Q3 | $1.25M | Sell |
16,566
-68
| -0.4% | -$4.66K | 1% | 28 |
|
|
2019
Q2 | $1.21M | Sell |
16,634
-30
| -0.2% | -$2.36K | 0.99% | 28 |
|
|
2019
Q1 | $1.34M | Buy |
16,664
+91
| +0.5% | +$7.45K | 1.13% | 26 |
|
|
2018
Q4 | $1.53M | Buy |
16,573
+79
| +0.5% | +$6.95K | 1.46% | 25 |
|
|
2018
Q3 | $1.56M | Sell |
16,494
-800
| -5% | -$75.9K | 1.29% | 24 |
|
|
2018
Q2 | $1.6M | Sell |
17,294
-1,413
| -8% | -$138K | 1.5% | 22 |
|
|
2018
Q1 | $1.77M | Sell |
18,707
-20,371
| -52% | -$2.24M | 1.69% | 22 |
|
|
2017
Q4 | $3.78M | Buy |
+39,078
| New | +$3.68M | 3.7% | 9 |
|
Other funds holding ABBV
Wells Trecaso Financial Group's ABBV Position: Q3 2025 in Review
Wells Trecaso Financial Group reduced its AbbVie (ABBV) stake by 22% in Q3 2025, selling an estimated $360K and leaving 6,172 shares worth $1.43M. The position accounts for 0.68% of the portfolio, ranked #39.
Wells Trecaso Financial Group first reported a position in ABBV in Q4 2017 and has held it in 32 quarters since. The position peaked at $3.78M in Q4 2017. 3,907 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Wells Trecaso Financial Group held 6,172 shares of AbbVie worth $1.43M as of Q3 2025.
- Wells Trecaso Financial Group sold 1,767 AbbVie shares in Q3 2025, an estimated $360K.
- AbbVie made up 0.68% of Wells Trecaso Financial Group's portfolio in Q3 2025, its #39 holding.
- Wells Trecaso Financial Group first reported a position in AbbVie in Q4 2017 and has held it in 32 quarters since.
- Wells Trecaso Financial Group's AbbVie position peaked at $3.78M in Q4 2017.
- 3,907 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Wells Trecaso Financial Group's 13F filing for Q3 2025, filed 5 Nov 2025.